(Q44641537)

English

Daptomycin against multiple drug-resistant staphylococcus and enterococcus isolates in an in vitro pharmacodynamic model with simulated endocardial vegetations

scientific article published on November 1, 2003

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Daptomycin against multiple drug-resistant staphylococcus and enterococcus isolates in an in vitro pharmacodynamic model with simulated endocardial vegetations (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

multiple drug resistance

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

Michael J Rybak

2

object named as

Michael J Rybak

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

author name string

Raymond Cha

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14596973

28 March 2024

publication date

1 November 2003

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0732889303001196?httpAccept=text/xml

1 reference

10.1016/S0732-8893(03)00119-6

https://api.crossref.org/works/10.1016/S0732-8893(03)00119-6

28 March 2024

https://api.elsevier.com/content/article/PII:S0732889303001196?httpAccept=text/plain

1 reference

10.1016/S0732-8893(03)00119-6

https://api.crossref.org/works/10.1016/S0732-8893(03)00119-6

28 March 2024

Diagnostic Microbiology and Infectious Disease

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

47

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

539-546

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

In vitro activities of daptomycin, arbekacin, vancomycin, and gentamicin alone and/or in combination against glycopeptide intermediate-resistant Staphylococcus aureus in an infection model

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900119-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Bactericidal activities of two daptomycin regimens against clinical strains of glycopeptide intermediate-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecium, and methicillin-resistant Staphylococcus aureus isolates in an in vi

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900119-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Daptomycin disrupts membrane potential in growing Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900119-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Staphylococcal bacteremia and endocarditis: state of the art.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900119-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Daptomycin or teicoplanin in combination with gentamicin for treatment of experimental endocarditis due to a highly glycopeptide-resistant isolate of Enterococcus faecium

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900119-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Daptomycin Dose-Effect Relationship against Resistant Gram-Positive Organisms

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900119-6

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibiotic

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900119-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Staphylococcal sepsis. The changing pattern of disease and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900119-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The emergence of decreased susceptibility to vancomycin in Staphylococcus epidermidis.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900119-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacodynamics of daptomycin and vancomycin on Enterococcus faecalis and Staphylococcus aureus demonstrated by studies of initial killing and postantibiotic effect and influence of Ca2+ and albumin on these drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900119-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacodynamics of vancomycin and ampicillin alone and in combination with gentamicin once daily or thrice daily against Enterococcus faecalis in an in vitro infection model

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900119-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Daptomycin compared with teicoplanin and vancomycin for therapy of experimental Staphylococcus aureus endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900119-6

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro pharmacodynamic effects of concentration, pH, and growth phase on serum bactericidal activities of daptomycin and vancomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900119-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of protein binding of daptomycin on MIC and antibacterial activity

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900119-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacodynamics of daptomycin in a murine thigh model of Staphylococcus aureus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900119-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Staphylococcus aureus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900119-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Enterococcal Endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900119-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential increased survival of staphylococci and limited ultrastructural changes in the core of infected fibrin clots after daptomycin administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900119-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Bactericidal activities of peptide antibiotics against multidrug-resistant Enterococcus faecium

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900119-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Once-daily dosing in dogs optimizes daptomycin safety

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900119-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics and bactericidal rates of daptomycin and vancomycin in intravenous drug abusers being treated for gram-positive endocarditis and bacteremia

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900119-6

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against Staphylococci and Enterococci, including vancomycin- intermediate and -resistant strains

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900119-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Emergence of vancomycin resistance in coagulase-negative staphylococci

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900119-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of daptomycin for gram-positive infections

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900119-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Daptomycin: a novel agent for Gram-positive infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900119-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900119-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Vancomycin-resistant Staphylococcus aureus: infection control considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900119-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0732-8893(03)00119-6

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

release_6lpsteavlfe3rooctwpxaathz4

1 reference

https://api.fatcat.wiki/v0/release/6lpsteavlfe3rooctwpxaathz4

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44641537&oldid=2144449873"